Alzheimer's disease (AD), the most common form of sporadic or late-onset dementia, is characterized by progressive cognitive and functional impairment. Although the clinical tests currently performed are rather accurate, a definitive diagnosis can still only be made by examining the brain tissue after death. Postmortem diagnosis of AD relies in part on the accurate detection of senile plaques (SPs) and neurofibrillary tangles (NFTs), the two major defining neuropathological features of AD. [1] [2] [3] While NFTs consist of bundles of filaments of hyperphosphorylated microtubule-associated protein, tau, 4 SPs contain mainly insoluble Aβ40 and Aβ42 peptides which are produced by a sequence of proteolytic cleavages from the amyloid precursor protein (APP). By targeting the cortical Aβ load, in vivo imaging by SPECT or PET has the potential to support both the earlier diagnosis by assessing a histologically confirmed AD-specific target and the monitoring of the effects of amyloid lowering therapeutic approaches.
Currently, several promising amyloid PET tracers were designed and successfully synthesized to image SPs or NFTs or both in vivo and have been used in clinical trial. Based on the benzothiazole and stilbene core structures, the two PET tracer compounds [ [13] [14] [15] ( Fig. 1 ) as candidate radiotracer for imaging SPs by SPECT. The positively charged quaternary heterocyclic nitrogen of the benzothiazolium group of the β-sheet specific staining dye thioflavine T limits the brain entry of this potential pharmacophore while its uncharged and lipophilic derivatives [ 11 C]6-Me-BTA-1 16 and BTA-1 17 ( Fig. 2) enter the brain in amounts sufficient for imaging by PET and show some preference for SPs staining. On the contrary, the quinoline based [ 11 C]BF-158 (Fig. 2) demonstrated preferred labeling of NFTs in AD brain sections by in vitro autoradiography. 18 By combining the chemical structures of SP-preferring benzothiazole and NFT-preferring quinoline, we have designed and synthesized a series of fluorinated indole derivatives by removing one C atom from the large conjugated 6-membered quinoline ring system for radiolabelling with 18 F (Fig. 2) . The resulting 5-membered indole structure offers the possibility to introduce a methyl group into the N-indole ring without parallel introduction of a positive charge into the molecule. The new compounds were investigated for their potential to displace the well described thioflavin-based β-sheet ligand [ 125 I]IMPY from its binding sites in postmortem AD brain. By this way, we expect that these compounds can be used to image SPs or NFTs or both.
Experimental Section
General. All the reagents used for chemical synthesis were commercial products without any further purification. 4-(1H-Indol-2-yl)benzenamine (3a): A mixture of 1a (1.08 g, 10 mmol) and 2a (1.35 g, 10 mmol) was added to 10 g of PPA and stirred at 80 o C for 5 h. After being cooled down to room temperature, the reaction mixture was poured into 200 mL of aqueous Na2CO3 solution and extracted with ethyl acetate (3 × 50 mL). The organic layer was separated, washed with brine, dried with anhydrous Na2CO3. The mixture was purified by column chromatography (EtOAc : petroleum ether = 1 : 2) to get yellowish solid (0.9 g; yield: 47%). The compounds 3b and 3c were prepared by the same method as 3a. 1-(4-(Methylamino)phenyl)ethanone (2b): 2a (1 g, 7.4 mmol) was dissolved in pyridine (3 mL). Ac2O (3 mL) was added and stirred for 30 minutes at 0 o C. The precipitate was filtrated, to get the product 4-acetylaminoacetophenone 1 g; yield 77%. To a solution of this acetyl derivative (0.2 g, 1.13 mmol) in anhydrous DMF (5 mL), was added NaH (48 mg, 2.0 mmol) at 0 o C within 30 min, CH3I (0.213 g, 1.5 mmol) was dropped slowly into the reaction mixture at 0 o C, keeping stirring for additional 1 h at room temperature. The mixture was quenched in 20 mL cool water, extracted with ethyl acetate and the solvent was evaporated. The residue was suspended in HCl (3 M) (20 mL) and refluxed for 5 h, neutralized with Na2CO3, and purified with column chromatography to get the product (2b, 0.17 g, yield 65%). N-Methyl-4-(1-methyl-1H-indol-2-yl)benzenamine (3d): Compound 3c (70 mg, 0.32 mmol) was dissolved in MeOH (10 mL) containing NaOCH3 (86 mg, 1.6 mmol). Paraformaldehyde (48 mg, 1.6 mmol) was added and the reaction mixture was refluxed for 6 hours. After cooling down to 0 o C, NaBH 4 (64 mg, 1.6 mmol) was added in portion and the mixture was refluxed for additional 2 h and then diluted with the 50 mL of cool water, extracted with ethyl acetate (3 × 20 mL). The organic layer was separated, washed with water and brine, dried (Na2CO3) and purified by column chromatography (ethyl acetate : petroleum ether = 1 : 4) to get yellowish solid (57 mg, yield 76%). 
N-(2-Fluoroethyl)-4-(1H-indol-2-yl)benzenamine (4a):
A mixture of compound 3a (0.1 g, 0.48 mmol), 1-bromo-2-fluoroethane (0.34 mg, 2.7 mmol) and Na2CO3 (0.1 g, 0.94 mmol) in dioxane (5 mL) was sealed in the bottle and stirred at 110 o C for 5 days. After being cooled to room temperature, the reaction mixture was poured into 40 mL of cold water, extracted with ethyl acetate, and purified by column chromatography to get the yellowish solid. 37 mg, yield 30%. 
N-(2-Fluoroethyl)-4-(1H-indol-2-yl)-N-methylbenzenamine (4b):
A mixture of compound 3b (50 mg, 0.2 mmol), 1-bromo-2-fluoroethane (0.25 g, 2 mmol) and Na2CO3 (0.11 g, 1 mmol) in MeCN (2 mL) was sealed in a bottle and heated to 80 o C. The reaction mixture was purified according to the 4a synthetic method to get yellowish solid (4b) 22 mg, yield 47%. The compounds 4c and 4d were synthesized using 3c and 3d respectively by the same method as 4b. The compound 4e was synthesized using 3d and 1-iodo-3-fluoropropane by the similiar reaction described in the preparation of 4b. Biological evaluation. 30 µm thick brain sections were obtained from frozen cortical tissue by cryostat sectioning mounted on glass microscope slides, dried at room temperature and stored at -25 o C until experiment. The frozen sections were thawed, incubated in 4% PBS-buffered paraformaldehyde on ice for 60 min, washed twice with PBS on ice for 3 min each, incubated in xylene at room temperature for 5 min, and eventually in 100%, 100%, 95%, 85% and 75% EtOH at room temperature for 1 min each. The PFA-fixed and xylene-incubated sections were dried at room temperature for 15 min and incubated with [
125 I]IMPY alone or in the presence of 100 µM IMPY to determine the nonspecific binding or 100 µM of the test compounds in PBS containing 10% EtOH at room temperature for 1 h. The sections were then incubated two times in saturated Li2CO3 in 40% EtOH and once in 40% EtOH for 2 min each. The sections were dried at room temperature and exposed with 125 I-sensitive imaging plates (Fuji Film, Tokyo, Japan) for 12 h. The screen plates were analysed using image analysis system BAS-1800 II Bioimaging Analyzer (Fuji Film, Japan). Quantitative analysis of the digitized autoradiopgraphs was performed by computer assisted microdensitometry (Aida 2.31, raytest, Germany) by measuring the photostimulated luminescence (PSL) per brain section and the area of the respective brain section (mm 
Results and Discussion
The Fischer-Indole synthesis has been widely studied and applied for the preparation of indole derivatives. 19 Polyphosphoric acid (PPA), as catalyst and solvent, plays an important role in the one-pot reaction. 20 As shown in Scheme 1, 3a was synthesized from 1a and 2a in PPA at 80 o C. 2a was acetylated first by acetic anhydride in pyridine followed by methylation with CH3I and NaH in DMF. After removal of the acetyl group (3 M HCl), N-methylaminoacetophenone (2b) was obtained, which was used to synthesize indole 3b with high yield. 3c was achieved by reaction of 1b with 2a according to the same procedure as described for 3a. The anilino group in 3c was monomethylated with paraformaldehyde, NaOCH 3 and NaBH 4 in methanol to get 3d. The 2-fluoroethyl derivatives 4a-d were achieved by the alkylation of 3a-d with 1-bromo-2-fluoroethane in dioxane or acetonitrile in the presence of Na2CO3. The homologous compound 4e was prepared from 3d and 1-fluoro-3-iodopropane with the same method of 4b. The 21 and has been widely used as radioligand to determine the K i values of candidate β-sheet ligands. Considering the similar chemical structure of IMPY and the newly synthesized indole derivatives, the radioligand and the test compounds are expected to interact comparably with β-sheet structures. IMPY and [ I according to the procedures described in the literature. 21 Autoradiographic investigation in vitro demonstrated that at 100 µM 4a, 4b, 4c displaced a higher amount of specific [ 125 I]IMPY binding to AD brain tissue than 4d and 4e (86 to 90% vs. 16 to 53% displacement of specific binding, respectively; Table 1 ). Thus, the indole derivatives which contain only secondary amines (4a) or carry a single methyl substitution either at the indole-N (4b) or aniline-N (4c) possess an affinity to IMPY-labelled sites comparable to the thioflavin T itself. However, the methylation of both the aniline-N and the indole-N in 4e and 4d, respectively, reduced the [ 125 I]IMPY displacement efficacy significantly. Compared to fluoroethyl substitution in 4d, the fluoropropyl substituted 4e is assumed to show a somewhat higher affinity to IMPYlabelled structures in AD brain slices.
In summary, in this work nine indole derivatives were successfully synthesized. Five fluorine-substituted compounds were investigated regarding their affinity to human AD brain tissue in vitro. Indole derivatives 4a, 4b, and 4c displayed the potential to develop 18 F-labeled PET tracers for imaging neuropathological hallmarks in AD brain in vivo.
